Showing results (231-240 of 273) with videos related to
Sort By:
Pageof 28
Frontiers in Immunology|May 14, 2024
<i>Saccharomyces cerevisiae</i> oral immunization in mice using multi-antigen of the African swine fever virus elicits a robust immune responseShuo Gao, Wenfeng Zuo, Chao Kang, et al.Antiviral Research|October 25, 2011
Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccineQunfeng Wu, Shaobo Xiao, Huiying Fan, et al.Scientific Reports|April 4, 2013
Insights into the increasing virulence of the swine-origin pandemic H1N1/2009 influenza virusWei Zou, Dijun Chen, Min Xiong, et al.Frontiers in Immunology|April 11, 2017
HIST1H1C Regulates Interferon-β and Inhibits Influenza Virus Replication by Interacting with IRF3Xiaokun Liu, Cha Yang, Yong Hu, et al.Vaccines|March 28, 2024
Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ Enterotoxigenic <i>Escherichia coli</i>Jiangxu Yu, Jiyang Fu, Hongshuo Liu, et al.Viruses|August 28, 2021
3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In VivoXuejin Zhao, Lianzhong Zhao, Ya Zhao, et al.Scientific Reports|October 10, 2015
Identification of cellular microRNA-136 as a dual regulator of RIG-I-mediated innate immunity that antagonizes H5N1 IAV replication in A549 cellsLianzhong Zhao, Jiping Zhu, Hongbo Zhou, et al.Cell Reports|March 30, 2022
Genome-wide CRISPR-Cas9 screening identifies the CYTH2 host gene as a potential therapeutic target of influenza viral infectionChenyang Yi, Cong Cai, Ze Cheng, et al.ACS Nano|March 27, 2023
Abiotic Synthetic Antibody Inhibitor with Broad-Spectrum Neutralization and Antiviral Efficacy against Escaping SARS-CoV-2 VariantsBingxue Li, Ya Zhao, Xuefan Wu, et al.FEMS Microbiology Letters|January 26, 2005
Construction and characterization of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance markerWeicheng Bei, Qigai He, Lin Yan, et al.Pageof 28